Primaa

The power of AI for Pathologists

Paris, France · Founded 2018 · $7.8M raised

Headquarters
Paris
Employees
11–50
Founded
2018
Business Model
B2B
Total Funding
$7.8M
Last Round
$7.8M Series BOct 2025
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Primaa is a MedTech company developing AI-based software for automated cancer diagnosis in histopathology. Founded in 2018 in Paris by pathologist Marie Sockeel, the company flagship product Cleo uses deep learning and computer vision to assist pathologists in identifying cancer biomarkers on whole slide images, with CE-marked solutions for breast cancer and — as of 2026 — the world first CE IVDR-certified AI tool for dermatopathology. With a team of 22 including PhDs, MDs, and data scientists, Primaa partners with leading digital pathology platforms including PathAI, Proscia, and Gestalt, and has expanded into the U.S. market.

Summary

Primaa is an Artificial Intelligence company based in Paris, France, founded in 2018. It has raised $7.8M in total across 3 rounds, most recently a $7.8M Series B round in Oct 2025. Investors include Elaia, MH Innov and Swen CP.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BOct 2025
$7.8M

Sign up to see all 3 events

Funding: Seed through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series FTotal funding$3.8BJan 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Primaa on Indexed.vc
<a href="https://indexed.vc/companies/primaa"><img src="https://indexed.vc/api/badge/company/primaa" alt="Primaa on Indexed.vc" width="260" height="76" /></a>